Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Multiple Myeloma 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

Cisplatin 22Magnetic Resonance Spectroscopy 15Specimen Handling 13Platinum 12Radiotherapy, Intensity-Modulated 111,2-diaminocyclohexaneplatinum II citrate 11Radiotherapy 10Radiation 10Carboplatin 9Surveys and Questionnaires 5Biopsy 5pembrolizumab 4Taxes 4Paclitaxel 4Nivolumab 4Docetaxel 4Chemoradiotherapy 4Cetuximab 4Observation 3Fluorodeoxyglucose F18 3(225)Ac-DOTA-c(RGDyK) 3durvalumab 2X-Rays 2Watchful Waiting 2Standard of Care 2Radiotherapy, Image-Guided 2Interviews as Topic 2Immunoglobulin G 2Fluorouracil 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Diphenhydramine × 90 days × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡